We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
176
Carson Wealth (CWM LLC)
Nebraska
$4K +$4.59K +450 New
DFCM
177
Dark Forest Capital Management
Puerto Rico
$3K -$27.9K -2,729 -88%
APC
178
Aspire Private Capital
North Carolina
$3K – – –
Baillie Gifford & Co
179
Baillie Gifford & Co
United Kingdom
$3K – – –
COCM
180
Charter Oak Capital Management
New Hampshire
$3K – – –
CMBA
181
C.M. Bidwell & Associates
Hawaii
$3K – – –
HNB
182
Huntington National Bank
Ohio
$3K – – –
WTA
183
Washington Trust Advisors
Massachusetts
$3K +$3.75K +367 New
CWS
184
Confluence Wealth Services
Pennsylvania
$3K +$4.39K +430 New
BAM
185
Bellevue Asset Management
Washington
$2K -$143 -14 -8%
EBA
186
Eagle Bay Advisors
New York
$2K – – –
First Manhattan
187
First Manhattan
New York
$2K – – –
PA
188
Parallel Advisors
California
$2K – – –
BHWM
189
Beaird Harris Wealth Management
Texas
$2K +$2.04K +200 New
BEI
190
Benjamin Edwards Inc
Missouri
$2K +$2.46K +241 New
Rockefeller Capital Management
191
Rockefeller Capital Management
New York
$1K -$9.19K -900 -82%
EWM
192
Evermay Wealth Management
Virginia
$1K – – –
LWANC
193
Laurel Wealth Advisors (North Carolina)
North Carolina
$1K – – –
SGAM
194
Smith Group Asset Management
Texas
$1K – – –
CA
195
CoreCap Advisors
Michigan
$1K +$1.2K +117 New
Manulife (Manufacturers Life Insurance)
196
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$448 +$1.85K +181 +0.4%
VRS
197
Virginia Retirement Systems
Virginia
$102 +$1.02K +100 +0.9%
Point72 Asset Management
198
Point72 Asset Management
Connecticut
– -$17.1M -1,600,486 Closed
American Century Companies
199
American Century Companies
Missouri
– -$3.52M -329,774 Closed
JF
200
Jump Financial
Illinois
– -$752K -70,326 Closed
5 6 7
8
9

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.